- Gtcbio Company News Section

Gtcbio Information
  • Kristen Starkey
  • Phone: (626) 256-6405
  • URL:
  • GTC is a leading information center that provides quality forums, which facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community. Our conferences cover a variety of topics, such as stem cell therapeutics, infectious diseases, biotech partnering, pharmaceutical litigation, government regulation, bio-based chemicals and many more. Founded in 2002, GTC stimulates scientific discussions, offers key business insights, and promotes partnering and deal-making in the ever-changing biotech and pharmaceutical world.
Gtcbio Press Release -

  • Rebecca Leary, Novartis, to Present at 2nd Cancer Markers & Liquid Biopsies
  • Rebecca Leary, Research Investigator III, Oncology Research at Novartis Institutes for Biomedical Research, will give a presentation on, "Characterizing the Cancer Genome from the Circulation" at GTCbio's 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA.
  • April 28, 2016
  • Jared Cumming, Merck, to give a presentation at GTCbio's Protease Inhibitors Conference
  • Jared Cumming, Director, Global Chemistry at Merck, will give a distinguished speaker presentation on, "Discovery of Verubecestat (MK-8931): A beta-Secretase Inhibitor in Phase 3 Clinical Development for Alzheimer's Disease" at GTCbio's 2nd Protease Inhibitors in Drug Discovery Conference to be held on March 1-2, 2016 in San Diego, CA.
  • February 18, 2016
  • John Herrmann, CSO, Eli Lilly to Keynote at Novel Cancer Therapeutics Summit - July 7-8, 2014 Boston
  • John Herrmann, Chief Science Officer of Global External Research & Development, Oncology at Eli Lilly To Give a Keynote Presentation on "Partnering with Lilly Oncology: Current Priorities, NYC Innovation Hub Model & Possible Future States" at the Novel Cancer Therapeutics Summit 2014 to be held on July 7-8, 2014, in Boston, MA. This summit includes two parallel conferences focused on both the research, and business perspectives in oncology.
  • May 22, 2014
  • Richard Beger, FDA to Keynote at Metabolomics Conference on May 22-23, 2014 in Cambridge, MA
  • Richard Beger, Director of the Biomarkers and Alternative Models Branch Division of Systems Biology at the National Center for Toxicological Research, FDA to give a keynote presentation on "Metabolomics of Acetaminophen Overdose in Rodents and Children" at the Metabolomics Conference - Advances & Applications in Human Disease to be held on May 22-23, 2014 in Cambridge, MA by GTC.
  • April 04, 2014